[1]
|
Brunt, E.M., Wong, V.W., Nobili, V., Day, C.P., Sookoian, S., Maher, J.J., Bugianesi, E., Sirlin, C.B., Neuschwander- Tetri, B.A. and Rinella, M.E. (2015) Nonalcoholic Fatty Liver Disease. Nature Reviews Disease Primers, 1, Article No. 15080. https://doi.org/10.1038/nrdp.2015.80
|
[2]
|
Riazi, K., Azhari, H., Charette, J.H., Underwood, F.E., King, J.A., Afshar, E.E., Swain, M.G., Congly, S.E., Kaplan, G.G. and Shaheen, A.A. (2022) The Prevalence and Incidence of NAFLD Worldwide: A Systematic Review and Meta-Analysis. The Lancet Gastroenterology and Hepatology, 7, 851-861.
https://doi.org/10.1016/S2468-1253(22)00165-0
|
[3]
|
Adams, L.A., Lymp, J.F., St Sauver, J., Sanderson, S.O., Lindor, K.D., Feldstein, A. and Angulo, P. (2005) The Natural History of Nonalcoholic Fatty Liver Disease: A Popula-tion-Based Cohort Study. Gastroenterology, 129, 113-121.
https://doi.org/10.1053/j.gastro.2005.04.014
|
[4]
|
Jou, J., Choi, S.S. and Diehl, A.M. (2008) Mechanisms of Dis-ease Progression in Nonalcoholic Fatty liver Disease. Seminars in Liver Disease, 28, 370-379. https://doi.org/10.1055/s-0028-1091981
|
[5]
|
Wang, X.J. and Malhi, H. (2018) Nonalcoholic Fatty Liver Disease. Annals of Internal Medicine, 169, C65-C80.
https://doi.org/10.7326/IsTranslatedFrom_AITC201811060_Japanese
|
[6]
|
Zhou, J., Zhou, F., Wang, W., et al. (2020) Epidemiological Features of NAFLD from 1999 to 2018 in China. Hepatology, 71, 1851-1864. https://doi.org/10.1002/hep.31150
|
[7]
|
中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 非酒精性脂肪性肝病防治指南(2018年更新版) [J]. 临床肝胆病杂志, 2018, 34(5): 947-957.
https://doi.org/10.3969/j.issn.1001-5256.2018.05.007
|
[8]
|
颜士岩, 范建高. 非酒精性脂肪性肝病相关肝细胞癌的诊断和治疗[J]. 临床肝胆病杂志, 2021, 37(8): 1748-1752.
https://doi.org/10.3969/j.issn.1001-5256.2021.08.002
|
[9]
|
Loney, P.L., Chambers, L.W., Bennett, K.J., et al. (1998) Critical Appraisal of the Health Research Literature: Prevalence or Incidence of a Health Problem. Chronic Dis-eases in Canada, 19, 170-176.
|
[10]
|
Zhou, J., Zhou, F., Wang, W., Zhang, X.J., Ji, Y.X., Zhang, P., She, Z.G., Zhu, L., Cai, J. and Li, H. (2020) Epidemiological Features of NAFLD from 1999 to 2018 in China. Hepatology, 71, 1851-1864.
https://doi.org/10.1002/hep.31150
|
[11]
|
Wong, V.W., Chan, W.K., Chitturi, S., Chawla, Y., Dan, Y.Y., Duseja, A., Fan, J., Goh, K.L., Hamaguchi, M., Hashimoto, E., Kim, S.U., Lesmana, L.A., Lin, Y.C., Liu, C.J., Ni, Y.H., Sollano, J., Wong, S.K., Wong, G.L., Chan, H.L. and Farrell, G. (2018) Asia-Pacific Working Party on Non-Alcoholic Fatty Liver Disease Guidelines 2017-Part 1: Definition, Risk Factors and Assessment. Journal of Gastroenterology and Hepatology, 33, 70-85.
https://doi.org/10.1111/jgh.13857
|
[12]
|
张天嵩. 基于二项式-正态层次模型框架下比例的贝叶斯Meta分析方法及实现[J]. 中国循证儿科杂志, 2019, 14(2): 123-128. https://doi.org/10.3969/j.issn.1673-5501.2019.02.009
|
[13]
|
Lee, C., Kim, J., Han, J., et al. (2022) Formyl Peptide Receptor 2 Determines Sex-Specific Differences in the Progression of Nonalcoholic Fatty Liver Disease and Steatohepa-titis. Nature Communications, 13, Article No. 578.
https://doi.org/10.1038/s41467-022-28138-6
|
[14]
|
Nikkanen, J., Leong, Y.A., Krause, W.C., et al. (2022) An Evo-lutionary Trade-Off between Host Immunity and Metabolism Drives Fatty Liver in Male Mice. Science, 378, 290-295. https://doi.org/10.1126/science.abn9886
|
[15]
|
中华医学会内分泌学分会. 非酒精性脂肪性肝病与相关代谢紊乱诊疗共识(第二版) [J]. 临床肝胆病杂志, 2018, 34(10): 2103-2108. https://doi.org/10.3969/.issn.1001-5256.2018.10.010
|
[16]
|
Younossi, Z.M., Golabi, P., de Avila, L., et al. (2019) The Global Epidemiology of NAFLD and NASH in Patients with Type 2 Diabetes: A Systematic Review and Me-ta-Analysis. Journal of Hepatology, 71, 793-801.
https://doi.org/10.1016/j.jhep.2019.06.021
|
[17]
|
Hazlehurst, J.M., Woods, C., Marjot, T., et al. (2016) Non-Alcoholic Fatty Liver Disease and Diabetes. Metabolism: Clinical and Experimental, 65, 1096-1108. https://doi.org/10.1016/j.metabol.2016.01.001
|
[18]
|
Guo, K.F., et al. (2017) Non-Alcoholic Fatty Liver Disease Is Associated with Late But Not Early Atherosclerotic Lesions in Chinese Inpatients with Type 2 Diabetes. Journal of Dia-betes and Its Complications, 31, 80-85.
https://doi.org/10.1016/j.jdiacomp.2016.09.008
|
[19]
|
Vatner, D.F., Majumdar, S.K., Kumashiro, N., et al. (2015) Insulin-Independent Regulation of Hepatic Triglyceride Synthesis by Fatty Acids. Proceedings of the National Academy of Sciences of the United States of America, 112, 1143-1148. https://doi.org/10.1073/pnas.1423952112
|
[20]
|
Ng, C.H., Lin, S.Y., Chin, Y.H., et al. (2022) Antidiabetic Medications for Type 2 Diabetics with Nonalcoholic Fatty Liver Disease: Evidence from a Network Meta-Analysis of Randomized Controlled Trials. Endocrine Practice, 28, 223-230. https://doi.org/10.1016/j.eprac.2021.09.013
|
[21]
|
中华医学会内分泌学分会, 中华医学会糖尿病学分会. 中国成人2型糖尿病合并非酒精性脂肪性肝病管理专家共识[J]. 中华内分泌代谢杂志, 2021, 37(7): 589-598. https://doi.org/10.3760/cma.j.cn311282-20210105-00016
|
[22]
|
Smith, G.I., Shankaran, M., Yoshino, M., et al. (2020) Insulin Resistance Drives Hepatic De Novo Lipogenesis in Nonalcoholic Fatty Liver Disease. Journal of Clinical Investigation, 130, 1453-1460.
https://doi.org/10.1172/JCI134165
|
[23]
|
Ortiz-Lopez, C., Lomonaco, R., Orsak, B., et al. (2012) Prevalence of Pre-diabetes and Diabetes and Metabolic Profile of Patients with Nonalcoholic Fatty Liver Disease (NAFLD). Diabetes Care, 35, 873-878.
https://doi.org/10.2337/dc11-1849
|
[24]
|
Hagström, H., Nasr, P., Ekstedt, M., et al. (2018) Risk for Development of Severe Liver Disease in Lean Patients with Nonalcoholic Fatty Liver Disease: A Long-Term Follow-Up Study. Hepatol-ogy Communications, 2, 48-57.
https://doi.org/10.1002/hep4.1124
|
[25]
|
Patel, P.J., Banh, X., Horsfall, L.U., et al. (2018) Underappreciation of Non-Alcoholic Fatty Liver Disease by Primary Care Clinicians: Limited Awareness of Surrogate Markers of Fibrosis. Internal Medicine Journal, 48, 144-151.
https://doi.org/10.1111/imj.13667
|
[26]
|
Valery, P.C. and Powell, E.E. (2019) Engaging Primary Care Clinicians in the Assessment of NAFLD. Nature Reviews Gastroenterology & Hepatology, 16, 458-460. https://doi.org/10.1038/s41575-019-0164-4
|
[27]
|
Ratziu, V., Charlotte, F., Heurtier, A., et al. (2005) Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease. Gastroenterology, 128, 1898-1906. https://doi.org/10.1053/j.gastro.2005.03.084
|
[28]
|
Nalbantoglu, I.L. and Brunt, E.M. (2014) Role of Liver Biopsy in Nonalcoholic Fatty Liver Disease. World Journal of Gastroenterology, 20, 9026-9037.
|
[29]
|
Hernaez, R., Lazo, M., Bonekamp, S., et al. (2011) Diagnostic Accuracy and Reliability of Ultrasonography for the Detection of Fatty Liver: A Meta-Analysis. Hepatology, 54, 1082-1090. https://doi.org/10.1002/hep.24452
|